＜ 目次 ＞
はじめに目次１．特許出願時に遺伝資源の出所開示を求める制度の状況
１－１ 概要 ·····························································································
１－２ インド(1)遺伝資源の出所開示制度の内容 ·······························································(2)開示義務違反に対する措置・罰則 ····························································(3)遺伝資源へのアクセス承認機関の状況 ······················································(4)法律事務所の実情と意見········································································(5)企業の実情と意見·················································································
１－３ ブラジル(1)遺伝資源の出所開示制度の内容 ·······························································(2)開示義務違反に対する措置・罰則 ····························································(3)遺伝資源へのアクセス手続きと承認機関の状況···········································(4)ブラジル INPI の実情と意見···································································(5)法律事務所の実情と意見 ········································································(6)企業の実情と意見·················································································(7)NGO の実情と意見···············································································
１－４ ペルー(1)遺伝資源の出所開示制度の内容 ·······························································(2)｢伝統的知識｣に関する開示義務違反に対する措置・罰則·······························(3)遺伝資源へのアクセス手続きと承認機関の状況···········································(4)INDECOPI の実情と意見 ······································································(5)法律事務所の実情と意見········································································
１－５ コスタリカ(1)遺伝資源の出所開示制度の内容 ·······························································(2)遺伝資源へのアクセス手続きと承認機関の状況···········································(3)産業財産登記所の実情と意見 ··································································(4)法律事務所の実情と意見········································································(5)企業の実情と意見·················································································(6)NGO の実情と意見···············································································
１－６ ノルウェー(1)遺伝資源の出所開示制度の内容 ·······························································(2)開示義務違反に対する措置・罰則 ····························································

(3)遺伝資源へのアクセス承認機関の状況 ······················································(4)ノルウェー特許庁の実情と意見 ·······························································(5)ノルウェーの遺伝資源出所開示に関する研究者の意見··································
１－７ デンマーク(1)遺伝資源の出所開示制度の内容 ·······························································(2)開示義務違反に対する措置・罰則 ····························································(3)遺伝資源へのアクセス承認機関の状況 ······················································(4)デンマーク特許庁の実情と意見 ·······························································(5)法律事務所の実情と意見········································································(6)企業の実情と意見·················································································
１－８ スイス(1)遺伝資源の出所開示制度の内容 ·······························································(2)開示義務違反に対する措置・罰則 ····························································(3)遺伝資源へのアクセス承認機関の状況 ······················································(4)スイス連邦知的財産庁の実情と意見 ·························································(5)法律事務所の実情と意見········································································(6)企業の実情と意見·················································································
２．国際会議における遺伝資源出所開示の議論
２－１ 議論の概要·····················································································
２－２ 国際会議における議論の状況(1)CBD/ COP7

(2004 年 2 月 9 日～20 日)··················(2)WTO/ TRIPS 理事会(2004 月 3 月 8 日)····························(3)WIPO/ IGC6(2004 年 3 月 15 日～19 日) ················(4) WIPO/ SCP10(2004 年 5 月 10 日～14 日) ················(5) WTO / TRIPS 理事会(2004 月 6 月 16 日)··························(6) WTO / TRIPS 理事会(2004 月 9 月 21 日)··························(7)第 31 回 WIPO 一般総会

(2004 年 9 月 27 日～10 月 5 日)··········(8) WIPO/ IGC7(2004 年 11 月 1 日～5 日)··················(9) WTO / TRIPS 理事会(2004 月 12 月 1 日～2 日)··················(10) WIPO/ SCP カサブランカ非公式会合 (2005 年 2 月 16 日～17 日) ················(11) CBD/ 第 3 回 Ad hocABS 作業部会

(2005 年 2 月 14 日～18 日) ················(12) WTO/ TRIPS 理事会(2005 年 3 月 8～9 日、31 日) ·············(13) WIPO/ SCP 11(2005 年 6 月 1 日～2 日) ···················(14) WIPO/ Ad hoc IGC 政府間会合(2005 年 6 月 3 日）··························(15) WIPO/ IGC８(2005 月 6 月 6 日～10 日）················(16) WTO/ TRIPS 理事会(2005 年 6 月 14～15 日)····················(17) 第 32 回 WIPO 一般総会

(2005 年 9 月 26 日～10 月 6 日）········

３．各国から受領したアンケート回答
３－１ インド(1) Anand and Anand 法律事務所································································(2)インド企業··························································································
３－２ ブラジル(1)ブラジル INPI ·····················································································(2)Trench, Rossi e Watanabe Advogados 法律事務所·······································(3)ブラジル企業·······················································································(4)ブラジル NGO·····················································································
３－３ ペルー(1)Estudio Colmenares S.R.L.法律事務所·····················································
３－４ コスタリカ(1)産業財産登記所····················································································(2)Castro & Pal Asociados 法律事務所 ·························································(3)コスタリカ企業····················································································(4)コスタリカ NGO··················································································
３－５ ノルウェー(1)ノルウェーの研究者 ··············································································
３－６ デンマーク(1)デンマーク特許庁·················································································(2)Plougmann & Vingtoft a/s 法律事務所······················································(3)デンマーク企業····················································································
３－７ スイス(1)スイス連邦知的財産庁 ···········································································(2)VISCHER Anwälte und Notare 法律事務所 ··············································(3)スイス企業··························································································